RT @Pulmmed_CE
1a) Welcome to a new #accredited #tweetorial on strategies for implementing optimal first-line treatment of patients with extensive stage @small_cell #lungcancer (#ES_SCLC). Key considerations: recently published guidelines, available options, emerging therapies.